{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:46:05Z","timestamp":1793159165756,"version":"4.5.0"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003528","name":"Consumers, Health and Food Executive Agency","doi-asserted-by":"publisher","award":["2012 1201"],"award-info":[{"award-number":["2012 1201"]}],"id":[{"id":"10.13039\/501100003528","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Acid Sphingomyelinase Deficiency (ASMD) is a rare autosomal recessive disorder caused by mutations in the\n                      <jats:italic>SMPD1<\/jats:italic>\n                      gene. This rarity contributes to misdiagnosis, delayed diagnosis and barriers to good care. There are no published national or international consensus guidelines for the diagnosis and management of patients with ASMD. For these reasons, we have developed clinical guidelines that defines standard of care for ASMD patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The information contained in these guidelines was obtained through a systematic literature review and the experiences of the authors in their care of patients with ASMD. We adopted the Appraisal of Guidelines for Research and Evaluation (AGREE II) system as method of choice for the guideline development process.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The clinical spectrum of ASMD, although a continuum, varies substantially with subtypes ranging from a fatal infantile neurovisceral disorder to an adult-onset chronic visceral disease. We produced 39 conclusive statements and scored them according to level of evidence, strengths of recommendations and expert opinions. In addition, these guidelines have identified knowledge gaps that must be filled by future research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These guidelines can inform care providers, care funders, patients and their carers about best clinical practice and leads to a step change in the quality of care for patients with ASMD with or without enzyme replacement therapy (ERT).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-023-02686-6","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T10:02:38Z","timestamp":1681725758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann\u2013Pick disease types A, B and A\/B)"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3629-2338","authenticated-orcid":false,"given":"Tarekegn","family":"Geberhiwot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Wasserstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subadra","family":"Wanninayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun Christopher","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lidove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Imrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hopkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"de Vicente Corbeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Madathil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Ezg\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Pettazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Sjouke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie T.","family":"Vanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"McGovern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Schuchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"2686_CR1","doi-asserted-by":"crossref","unstructured":"Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839\u201342","DOI":"10.1503\/cmaj.090449"},{"issue":"2","key":"2686_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0888-7543(92)90366-Z","volume":"12","author":"EH Schuchman","year":"1992","unstructured":"Schuchman EH, Levran O, Pereira LV, Desnick RJ. Structural organization and complete nucleotide sequence of the gene encoding human acid sphingomyelinase (SMPD1). Genomics. 1992;12(2):197\u2013205.","journal-title":"Genomics"},{"issue":"D1","key":"2686_CR3","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Jang W, Karapetyan K, Katz K, Liu C, Maddipatla Z, Malheiro A, McDaniel K, Ovetsky M, Riley G, Zhou G, Holmes JB, Kattman BL, Maglott DR. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2686_CR4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/humu.10212","volume":"21","author":"PD Stenson","year":"2003","unstructured":"Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN. Human gene mutation database (HGMD): 2003 update. Hum Mutat. 2003;21(6):577\u201381.","journal-title":"Hum Mutat"},{"issue":"5","key":"2686_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1086\/503750","volume":"78","author":"CM Simonaro","year":"2006","unstructured":"Simonaro CM, Park JH, Eliyahu E, Shtraizent N, McGovern MM, Schuchman EH. Imprinting at the SMPD1 locus: implications for acid sphingomyelinase-deficient Niemann\u2013Pick disease. Am J Hum Genet. 2006;78(5):865\u201370.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2686_CR6","first-page":"1","volume":"79","author":"A Niemann","year":"1914","unstructured":"Niemann A. Ein unbekanntes Krankheitsbild. Jahrb Kinderheilkd. 1914;79(1):1\u201310.","journal-title":"Jahrb Kinderheilkd."},{"key":"2686_CR7","first-page":"1483","volume":"23","author":"L Pick","year":"1927","unstructured":"Pick L. \u00dcber die lipoidzellige splenohepatomegalie typus Niemann\u2013Pick als Stoffwechselerkrankung. Med Klin (Munich). 1927;23:1483\u20136.","journal-title":"Med Klin (Munich)"},{"key":"2686_CR8","first-page":"1128","volume":"76","author":"U Pf\u00e4ndler","year":"1946","unstructured":"Pf\u00e4ndler U. La maladie de Niemann\u2013Pick dans le cadre des lipoidoses. Schweiz Med Wschr. 1946;76:1128\u201331.","journal-title":"Schweiz Med Wschr."},{"issue":"1","key":"2686_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-195802000-00001","volume":"37","author":"AC Crocker","year":"1958","unstructured":"Crocker AC, Farber S. Niemann\u2013Pick disease: a review of eighteen patients. Medicine (Baltimore). 1958;37(1):1\u201395.","journal-title":"Medicine (Baltimore)"},{"issue":"35","key":"2686_CR10","doi-asserted-by":"publisher","first-page":"16769","DOI":"10.1016\/S0021-9258(18)66632-3","volume":"261","author":"HS Kruth","year":"1986","unstructured":"Kruth HS, Comly ME, Butler JD, Vanier MT, Fink JK, Wenger DA, Patel S, Pentchev PG. Type C Niemann\u2013Pick disease. Abnormal metabolism of low density lipoprotein in homozygous and heterozygous fibroblasts. J Biol Chem. 1986;261(35):16769\u201374.","journal-title":"J Biol Chem."},{"issue":"5323","key":"2686_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1126\/science.277.5323.228","volume":"277","author":"ED Carstea","year":"1997","unstructured":"Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, Gu J, Rosenfeld MA, Pavan WJ, Krizman DB, Nagle J, Polymeropoulos MH, Sturley SL, Ioannou YA, Higgins ME, Comly M, Cooney A, Brown A, Kaneski CR, Blanchette-Mackie EJ, Dwyer NK, Neufeld EB, Chang TY, Liscum L, Strauss JF 3rd, Ohno K, Zeigler M, Carmi R, Sokol J, Markie D, O\u2019Neill RR, van Diggelen OP, Elleder M, Patterson MC, Brady RO, Vanier MT, Pentchev PG, Tagle DA. Niemann\u2013Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science. 1997;277(5323):228\u201331.","journal-title":"Science"},{"issue":"5500","key":"2686_CR12","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1126\/science.290.5500.2298","volume":"290","author":"S Naureckiene","year":"2000","unstructured":"Naureckiene S, Sleat DE, Lackland H, Fensom A, Vanier MT, Wattiaux R, Jadot M, Lobel P. Identification of HE1 as the second gene of Niemann\u2013Pick C disease. Science. 2000;290(5500):2298\u2013301.","journal-title":"Science"},{"issue":"2","key":"2686_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1073\/pnas.55.2.366","volume":"55","author":"RO Brady","year":"1966","unstructured":"Brady RO, Kanfer JN, Mock MB, Fredrickson DS. The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann\u2013Pick diseae. Proc Natl Acad Sci USA. 1966;55(2):366\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2686_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10545-005-5671-5","volume":"28","author":"H Pavl\u016f-Pereira","year":"2005","unstructured":"Pavl\u016f-Pereira H, Asfaw B, Poupctov\u00e1 H, Ledvinov\u00e1 J, Sikora J, Vanier MT, Sandhoff K, Zeman J, Novotn\u00e1 Z, Chudoba D, Elleder M. Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study. J Inherit Metab Dis. 2005;28(2):203\u201327.","journal-title":"J Inherit Metab Dis."},{"issue":"9","key":"2686_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/gim.2017.7","volume":"19","author":"MM McGovern","year":"2017","unstructured":"McGovern MM, Dionisi-Vici C, Giugliani R, Hwu P, Lidove O, Lukacs Z, Eugen Mengel K, Mistry PK, Schuchman EH, Wasserstein MP. Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency. Genet Med. 2017;19(9):967\u201374.","journal-title":"Genet Med"},{"issue":"1","key":"2686_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1089\/gte.1997.1.13","volume":"1","author":"EH Schuchman","year":"1997","unstructured":"Schuchman EH, Miranda SR. Niemann\u2013Pick disease: mutation update, genotype\/phenotype correlations, and prospects for genetic testing. Genet Test. 1997;1(1):13\u20139.","journal-title":"Genet Test"},{"issue":"5","key":"2686_CR17","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s10545-007-0632-9","volume":"30","author":"EH Schuchman","year":"2007","unstructured":"Schuchman EH. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann\u2013Pick disease. J Inherit Metab Dis. 2007;30(5):654\u201363.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"2686_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","volume":"12","author":"R Pinto","year":"2004","unstructured":"Pinto R, Caseiro C, Lemos M, Lopes L, Fontes A, Ribeiro H, Pinto E, Silva E, Rocha S, Marc\u00e3o A, Ribeiro I, Lacerda L, Ribeiro G, Amaral O, S\u00e1 Miranda MC. Prevalence of lysosomal storage diseases in Portugal. Eur J Hum Genet. 2004;12(2):87\u201392.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"2686_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10545-010-9093-7","volume":"33","author":"H Poupetov\u00e1","year":"2010","unstructured":"Poupetov\u00e1 H, Ledvinov\u00e1 J, Bern\u00e1 L, Dvor\u00e1kov\u00e1 L, Kozich V, Elleder M. The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations. J Inherit Metab Dis. 2010;33(4):387\u201396.","journal-title":"J Inherit Metab Dis"},{"key":"2686_CR20","doi-asserted-by":"publisher","first-page":"100344","DOI":"10.1016\/j.lanwpc.2021.100344","volume":"19","author":"SJ Chin","year":"2021","unstructured":"Chin SJ, Fuller M. Prevalence of lysosomal storage disorders in Australia from 2009 to 2020. Lancet Reg Health West Pac. 2021;19:100344.","journal-title":"Lancet Reg Health West Pac"},{"issue":"12","key":"2686_CR21","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1111\/apa.12807","volume":"103","author":"M Hult","year":"2014","unstructured":"Hult M, Darin N, von D\u00f6beln U, M\u00e5nsson JE. Epidemiology of lysosomal storage diseases in Sweden. Acta Paediatr. 2014;103(12):1258\u201363.","journal-title":"Acta Paediatr"},{"issue":"4","key":"2686_CR22","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbamcr.2008.11.014","volume":"1793","author":"SU Walkley","year":"2009","unstructured":"Walkley SU, Vanier MT. Secondary lipid accumulation in lysosomal disease. Biochim Biophys Acta. 2009;1793(4):726\u201336.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2686_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/0005-2760(83)90218-7","volume":"750","author":"MT Vanier","year":"1983","unstructured":"Vanier MT. Biochemical studies in Niemann\u2013Pick disease. I. Major sphingolipids of liver and spleen. Biochim Biophys Acta. 1983;750(1):178\u201384.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"2686_CR24","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.3390\/ijms21072566","volume":"21","author":"B Breiden","year":"2020","unstructured":"Breiden B, Sandhoff K. Mechanism of secondary ganglioside and lipid accumulation in lysosomal disease. Int J Mol Sci. 2020;21(7):2566.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2686_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/BF00442673","volume":"140","author":"M Elleder","year":"1983","unstructured":"Elleder M, Cihula J. Niemann\u2013Pick disease (variation in the sphingomyelinase deficient group). Neurovisceral phenotype (A) with an abnormally protracted clinical course and variable expression of neurological symptomatology in three siblings. Eur J Pediatr. 1983;140(4):323\u20138.","journal-title":"Eur J Pediatr."},{"issue":"2","key":"2686_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1023\/A:1022501702403","volume":"24","author":"C Rodriguez-Lafrasse","year":"1999","unstructured":"Rodriguez-Lafrasse C, Vanier MT. Sphingosylphosphorylcholine in Niemann\u2013Pick disease brain: accumulation in type A but not in type B. Neurochem Res. 1999;24(2):199\u2013205.","journal-title":"Neurochem Res"},{"issue":"8","key":"2686_CR27","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1097\/PAS.0b013e31825793ff","volume":"36","author":"BL Thurberg","year":"2012","unstructured":"Thurberg BL, Wasserstein MP, Schiano T, O\u2019Brien F, Richards S, Cox GF, McGovern MM. Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann\u2013Pick disease type B). Am J Surg Pathol. 2012;36(8):1234\u201346.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2686_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.beem.2014.10.002","volume":"29","author":"EH Schuchman","year":"2015","unstructured":"Schuchman EH, Wasserstein MP. Types A and B Niemann\u2013Pick disease. Best Pract Res Clin Endocrinol Metab. 2015;29(2):237\u201347.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"2686_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1212\/01.wnl.0000194208.08904.0c","volume":"66","author":"MM McGovern","year":"2006","unstructured":"McGovern MM, Aron A, Brodie SE, Desnick RJ, Wasserstein MP. Natural history of type A Niemann\u2013Pick disease: possible endpoints for therapeutic trials. Neurology. 2006;66(2):228\u201332.","journal-title":"Neurology"},{"issue":"3","key":"2686_CR30","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ymgme.2012.06.015","volume":"107","author":"CE Hollak","year":"2012","unstructured":"Hollak CE, de Sonnaville ES, Cassiman D, Linthorst GE, Groener JE, Morava E, Wevers RA, Mannens M, Aerts JM, Meersseman W, Akkerman E, Niezen-Koning KE, Mulder MF, Visser G, Wijburg FA, Lefeber D, Poorthuis BJ. Acid sphingomyelinase (Asm) deficiency patients in the Netherlands and Belgium: disease spectrum and natural course in attenuated patients. Mol Genet Metab. 2012;107(3):526\u201333.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"2686_CR31","doi-asserted-by":"publisher","first-page":"e672","DOI":"10.1542\/peds.2004-0887","volume":"114","author":"MP Wasserstein","year":"2004","unstructured":"Wasserstein MP, Desnick RJ, Schuchman EH, Hossain S, Wallenstein S, Lamm C, McGovern MM. The natural history of type B Niemann\u2013Pick disease: results from a 10-year longitudinal study. Pediatrics. 2004;114(6):e672\u20137.","journal-title":"Pediatrics"},{"issue":"1","key":"2686_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13023-019-1029-1","volume":"14","author":"P Lipi\u0144ski","year":"2019","unstructured":"Lipi\u0144ski P, Kuchar L, Zakharova EY, Baydakova GV, \u0141ugowska A, Tylki-Szyma\u0144ska A. Chronic visceral acid sphingomyelinase deficiency (Niemann\u2013Pick disease type B) in 16 Polish patients: long-term follow-up. Orphanet J Rare Dis. 2019;14(1):55.","journal-title":"Orphanet J Rare Dis"},{"key":"2686_CR33","doi-asserted-by":"crossref","unstructured":"Cox GF, Clarke LA, Giugliani R, McGovern MM. Burden of illness in acid sphingomyelinase deficiency: a retrospective chart review of 100 patients. JIMD Reports. 2018;119\u201329","DOI":"10.1007\/8904_2018_120"},{"issue":"6","key":"2686_CR34","first-page":"1343","volume":"56","author":"K Ferlinz","year":"1995","unstructured":"Ferlinz K, Hurwitz R, Weiler M, Suzuki K, Sandhoff K, Vanier MT. Molecular analysis of the acid sphingomyelinase deficiency in a family with an intermediate form of Niemann\u2013Pick disease. Am J Hum Genet. 1995;56(6):1343\u20139.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2686_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-2003-44668","volume":"34","author":"K Harzer","year":"2003","unstructured":"Harzer K, Rolfs A, Bauer P, Zschiesche M, Mengel E, Backes J, Kustermann-Kuhn B, Bruchelt G, van Diggelen OP, Mayrhofer H, Kr\u00e4geloh-Mann I. Niemann\u2013Pick disease type A and B are clinically but also enzymatically heterogeneous: pitfall in the laboratory diagnosis of sphingomyelinase deficiency associated with the mutation Q292 K. Neuropediatrics. 2003;34(6):301\u20136.","journal-title":"Neuropediatrics"},{"issue":"Pt 4","key":"2686_CR36","first-page":"1050","volume":"130","author":"V Mihaylova","year":"2007","unstructured":"Mihaylova V, Hantke J, Sinigerska I, Cherninkova S, Raicheva M, Bouwer S, Tincheva R, Khuyomdziev D, Bertranpetit J, Chandler D, Angelicheva D, Kremensky I, Seeman P, Tournev I, Kalaydjieva L. Highly variable neural involvement in sphingomyelinase-deficient Niemann\u2013Pick disease caused by an ancestral Gypsy mutation. Brain. 2007;130(Pt 4):1050\u201361.","journal-title":"Brain"},{"issue":"4","key":"2686_CR37","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jpeds.2006.06.034","volume":"149","author":"MP Wasserstein","year":"2006","unstructured":"Wasserstein MP, Aron A, Brodie SE, Simonaro C, Desnick RJ, McGovern MM. Acid sphingomyelinase deficiency: prevalence and characterization of an intermediate phenotype of Niemann\u2013Pick disease. J Pediatr. 2006;149(4):554\u20139.","journal-title":"J Pediatr"},{"issue":"8","key":"2686_CR38","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/gim.2013.4","volume":"15","author":"MM McGovern","year":"2013","unstructured":"McGovern MM, Lippa N, Bagiella E, Schuchman EH, Desnick RJ, Wasserstein MP. Morbidity and mortality in type B Niemann\u2013Pick disease. Genet Med. 2013;15(8):618\u201323.","journal-title":"Genet Med"},{"issue":"4","key":"2686_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF00445608","volume":"128","author":"H Sogawa","year":"1978","unstructured":"Sogawa H, Horino K, Nakamura F, Kudoh T, Oyanagi K, Yamanouchi T, Minami R, Nakao T, Watanabe A, Matsuura Y. Chronic Niemann\u2013Pick disease with sphingomyelinase deficiency in two brothers with mental retardation. Eur J Pediatr. 1978;128(4):235\u201340.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"2686_CR40","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13023-021-01842-0","volume":"16","author":"MM McGovern","year":"2021","unstructured":"McGovern MM, Wasserstein MP, Bembi B, Giugliani R, Mengel KE, Vanier MT, Zhang Q, Peterschmitt MJ. Prospective study of the natural history of chronic acid sphingomyelinase deficiency in children and adults: eleven years of observation. Orphanet J Rare Dis. 2021;16(1):212.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2686_CR41","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1542\/peds.2007-3016","volume":"122","author":"MM McGovern","year":"2008","unstructured":"McGovern MM, Wasserstein MP, Giugliani R, Bembi B, Vanier MT, Mengel E, Brodie SE, Mendelson D, Skloot G, Desnick RJ, Kuriyama N, Cox GF. A prospective, cross-sectional survey study of the natural history of Niemann\u2013Pick disease type B. Pediatrics. 2008;122(2):e341\u20139.","journal-title":"Pediatrics"},{"issue":"2","key":"2686_CR42","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/ejhg.2015.89","volume":"24","author":"M Acu\u00f1a","year":"2016","unstructured":"Acu\u00f1a M, Mart\u00ednez P, Moraga C, He X, Moraga M, Hunter B, Nuernberg P, Guti\u00e9rrez RA, Gonz\u00e1lez M, Schuchman EH, Santos JL, Miquel JF, Mabe P, Zanlungo S. Epidemiological, clinical and biochemical characterization of the p.(Ala359Asp) SMPD1 variant causing Niemann\u2013Pick disease type B. Eur J Hum Genet. 2016;24(2):208\u201313.","journal-title":"Eur J Hum Genet."},{"issue":"3","key":"2686_CR43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ymgme.2016.05.001","volume":"118","author":"D Cassiman","year":"2016","unstructured":"Cassiman D, Packman S, Bembi B, Turkia HB, Al-Sayed M, Schiff M, Imrie J, Mabe P, Takahashi T, Mengel KE, Giugliani R, Cox GF. Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann\u2013Pick disease type B and B variant): Literature review and report of new cases. Mol Genet Metab. 2016;118(3):206\u201313.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"2686_CR44","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1148\/radiol.2381041696","volume":"238","author":"DS Mendelson","year":"2006","unstructured":"Mendelson DS, Wasserstein MP, Desnick RJ, Glass R, Simpson W, Skloot G, Vanier M, Bembi B, Giugliani R, Mengel E, Cox GF, McGovern MM. Type B Niemann\u2013Pick disease: findings at chest radiography, thin-section CT, and pulmonary function testing. Radiology. 2006;238(1):339\u201345.","journal-title":"Radiology"},{"issue":"1","key":"2686_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10545-012-9503-0","volume":"36","author":"M Wasserstein","year":"2013","unstructured":"Wasserstein M, Godbold J, McGovern MM. Skeletal manifestations in pediatric and adult patients with Niemann Pick disease type B. J Inherit Metab Dis. 2013;36(1):123\u20137.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2686_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jpeds.2004.02.048","volume":"145","author":"MM McGovern","year":"2004","unstructured":"McGovern MM, Pohl-Worgall T, Deckelbaum RJ, Simpson W, Mendelson D, Desnick RJ, Schuchman EH, Wasserstein MP. Lipid abnormalities in children with types A and B Niemann Pick disease. J Pediatr. 2004;145(1):77\u201381.","journal-title":"J Pediatr"},{"issue":"1","key":"2686_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13023-017-0572-x","volume":"12","author":"MM McGovern","year":"2017","unstructured":"McGovern MM, Avetisyan R, Sanson BJ, Lidove O. Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD). Orphanet J Rare Dis. 2017;12(1):41.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"2686_CR48","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1002\/ajmg.a.33077","volume":"149A","author":"SL Henderson","year":"2009","unstructured":"Henderson SL, Packman W, Packman S. Psychosocial aspects of patients with Niemann\u2013Pick disease, type B. Am J Med Genet A. 2009;149A(11):2430\u20136.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"2686_CR49","doi-asserted-by":"publisher","first-page":"20972","DOI":"10.1038\/s41598-021-99921-6","volume":"11","author":"R Pokrzywinski","year":"2021","unstructured":"Pokrzywinski R, Hareendran A, Nalysnyk L, Cowie S, Crowe J, Hopkin J, Joshi D, Pulikottil-Jacob R. Impact and burden of acid sphingomyelinase deficiency from a patient and caregiver perspective. Sci Rep. 2021;11(1):20972.","journal-title":"Sci Rep"},{"issue":"13\u201314","key":"2686_CR50","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cca.2011.03.012","volume":"412","author":"CS Elbin","year":"2011","unstructured":"Elbin CS, Olivova P, Marashio CA, Cooper SK, Cullen E, Keutzer JM, Zhang XK. The effect of preparation, storage and shipping of dried blood spots on the activity of five lysosomal enzymes. Clin Chim Acta. 2011;412(13\u201314):1207\u201312.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"2686_CR51","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s13023-022-02573-6","volume":"17","author":"A Dardis","year":"2022","unstructured":"Dardis A, Michelakakis H, Rozenfeld P, Fumic K, Wagner J, Pavan E, et al. Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1. Orphanet J Rare Dis. 2022;17(1):442.","journal-title":"Orphanet J Rare Dis"},{"issue":"3758","key":"2686_CR52","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.155.3758.86","volume":"155","author":"JP Kampine","year":"1967","unstructured":"Kampine JP, Brady RO, Kanfer JN, Feld M, Shapiro D. Diagnosis of gaucher\u2019s disease and Niemann\u2013Pick disease with small samples of venous blood. Science. 1967;155(3758):86\u20138.","journal-title":"Science"},{"key":"2686_CR53","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/978-1-4615-9071-2_65","volume":"101","author":"DA Wenger","year":"1978","unstructured":"Wenger DA. Assay of beta-glucosidase and sphingomyelinase for identification of patients and carriers of Gaucher\u2019s and Niemann\u2013Pick diseases. Adv Exp Med Biol. 1978;101:707\u201317.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"2686_CR54","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF01805712","volume":"1","author":"GT Besley","year":"1978","unstructured":"Besley GT. Studies on sphingomyelinase activity in cultured cells and leucocytes. J Inherit Metab Dis. 1978;1(1):29\u201333.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2686_CR55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0009-8981(79)90396-6","volume":"92","author":"L Svennerholm","year":"1979","unstructured":"Svennerholm L, H\u00e5kansson G, M\u00e5nsson JE, Vanier MT. The assay of sphingolipid hydrolases in white blood cells with labelled natural substrates. Clin Chim Acta. 1979;92(1):53\u201364.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"2686_CR56","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0009-8981(80)90309-5","volume":"106","author":"MT Vanier","year":"1980","unstructured":"Vanier MT, Revol A, Fichet M. Sphingomyelinase activities of various human tissues in control subjects and in Niemann\u2013Pick disease\u2014development and evaluation of a microprocedure. Clin Chim Acta. 1980;106(3):257\u201367.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"2686_CR57","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s10545-005-0105-y","volume":"28","author":"OP van Diggelen","year":"2005","unstructured":"van Diggelen OP, Voznyi YV, Keulemans JL, Schoonderwoerd K, Ledvinova J, Mengel E, Zschiesche M, Santer R, Harzer K. A new fluorimetric enzyme assay for the diagnosis of Niemann\u2013Pick A\/B, with specificity of natural sphingomyelinase substrate. J Inherit Metab Dis. 2005;28(5):733\u201341.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"2686_CR58","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1373\/clinchem.2014.225771","volume":"61","author":"MH Gelb","year":"2015","unstructured":"Gelb MH, Scott CR, Turecek F. Newborn screening for lysosomal storage diseases. Clin Chem. 2015;61(2):335\u201346.","journal-title":"Clin Chem"},{"issue":"5","key":"2686_CR59","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1373\/clinchem.2014.236448","volume":"61","author":"F Ghomashchi","year":"2015","unstructured":"Ghomashchi F, Barcenas M, Turecek F, Scott CR, Gelb MH. Reliable assay of acid sphingomyelinase deficiency with the mutation Q292K by tandem mass spectrometry. Clin Chem. 2015;61(5):771\u20132.","journal-title":"Clin Chem"},{"issue":"3","key":"2686_CR60","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10545-017-0126-3","volume":"41","author":"M Piraud","year":"2018","unstructured":"Piraud M, Pettazzoni M, Lavoie P, Ruet S, Pagan C, Cheillan D, Latour P, Vianey-Saban C, Auray-Blais C, Froissart R. Contribution of tandem mass spectrometry to the diagnosis of lysosomal storage disorders. J Inherit Metab Dis. 2018;41(3):457\u201377.","journal-title":"J Inherit Metab Dis"},{"key":"2686_CR61","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.dib.2016.06.052","volume":"8","author":"S Elliott","year":"2016","unstructured":"Elliott S, Buroker N, Cournoyer JJ, Potier AM, Trometer JD, Elbin C, Schermer MJ, Kantola J, Boyce A, Turecek F, Gelb MH, Scott CR. Dataset and standard operating procedure for newborn screening of six lysosomal storage diseases: by tandem mass spectrometry. Data Brief. 2016;8:915\u201324.","journal-title":"Data Brief"},{"issue":"4","key":"2686_CR62","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ymgme.2016.05.015","volume":"118","author":"S Elliott","year":"2016","unstructured":"Elliott S, Buroker N, Cournoyer JJ, Potier AM, Trometer JD, Elbin C, Schermer MJ, Kantola J, Boyce A, Turecek F, Gelb MH, Scott CR. Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry. Mol Genet Metab. 2016;118(4):304\u20139.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"2686_CR63","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41436-018-0129-y","volume":"21","author":"MP Wasserstein","year":"2019","unstructured":"Wasserstein MP, Caggana M, Bailey SM, Desnick RJ, Edelmann L, Estrella L, Holzman I, Kelly NR, Kornreich R, Kupchik SG, Martin M, Nafday SM, Wasserman R, Yang A, Yu C, Orsini JJ. The New York pilot newborn screening program for lysosomal storage diseases: report of the first 65,000 infants. Genet Med. 2019;21(3):631\u201340.","journal-title":"Genet Med"},{"issue":"1","key":"2686_CR64","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/0005-2760(83)90084-X","volume":"754","author":"T Kudoh","year":"1983","unstructured":"Kudoh T, Velkoff MA, Wenger DA. Uptake and metabolism of radioactively labeled sphingomyelin in cultured skin fibroblasts from controls and patients with Niemann\u2013Pick disease and other lysosomal storage diseases. Biochim Biophys Acta. 1983;754(1):82\u201392.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2686_CR65","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1399-0004.1985.tb00180.x","volume":"27","author":"MT Vanier","year":"1985","unstructured":"Vanier MT, Rousson R, Garcia I, Bailloud G, Juge MC, Revol A, Louisot P. Biochemical studies in Niemann\u2013Pick disease. III. In vitro and in vivo assays of sphingomyelin degradation in cultured skin fibroblasts and amniotic fluid cells for the diagnosis of the various forms of the disease. Clin Genet. 1985;27(1):20\u201332.","journal-title":"Clin Genet"},{"issue":"3","key":"2686_CR66","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1046\/j.1471-4159.1994.63031060.x","volume":"63","author":"D Graber","year":"1994","unstructured":"Graber D, Salvayre R, Levade T. Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann\u2013Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells. J Neurochem. 1994;63(3):1060\u20138.","journal-title":"J Neurochem"},{"issue":"3","key":"2686_CR67","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1172\/JCI117084","volume":"93","author":"CE Hollak","year":"1994","unstructured":"Hollak CE, van Weely S, van Oers MH, Aerts JM. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest. 1994;93(3):1288\u201392.","journal-title":"J Clin Invest."},{"issue":"40","key":"2686_CR68","doi-asserted-by":"publisher","first-page":"25680","DOI":"10.1074\/jbc.273.40.25680","volume":"273","author":"RG Boot","year":"1998","unstructured":"Boot RG, Renkema GH, Verhoek M, Strijland A, Bliek J, de Meulemeester TM, Mannens MM, Aerts JM. The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem. 1998;273(40):25680\u20135.","journal-title":"J Biol Chem"},{"issue":"5","key":"2686_CR69","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10545-006-0363-3","volume":"29","author":"M Ries","year":"2006","unstructured":"Ries M, Schaefer E, L\u00fchrs T, Mani L, Kuhn J, Vanier MT, Krummenauer F, Gal A, Beck M, Mengel E. Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann\u2013Pick disease type A\/B and C. J Inherit Metab Dis. 2006;29(5):647\u201352.","journal-title":"J Inherit Metab Dis"},{"issue":"56","key":"2686_CR70","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/scitranslmed.3001417","volume":"2","author":"FD Porter","year":"2010","unstructured":"Porter FD, Scherrer DE, Lanier MH, Langmade SJ, Molugu V, Gale SE, Olzeski D, Sidhu R, Dietzen DJ, Fu R, Wassif CA, Yanjanin NM, Marso SP, House J, Vite C, Schaffer JE, Ory DS. Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann\u2013Pick C1 disease. Sci Transl Med. 2010;2(56):56\u201381.","journal-title":"Sci Transl Med."},{"issue":"9","key":"2686_CR71","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.clinbiochem.2015.03.007","volume":"48","author":"G Klinke","year":"2015","unstructured":"Klinke G, Rohrbach M, Giugliani R, Burda P, Baumgartner MR, Tran C, Gautschi M, Mathis D, Hersberger M. LC\u2013MS\/MS based assay and reference intervals in children and adolescents for oxysterols elevated in Niemann\u2013Pick diseases. Clin Biochem. 2015;48(9):596\u2013602.","journal-title":"Clin Biochem"},{"key":"2686_CR72","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13023-015-0274-1","volume":"10","author":"AK Giese","year":"2015","unstructured":"Giese AK, Mascher H, Grittner U, Eichler S, Kramp G, Lukas J, te Vruchte D, Al Eisa N, Cortina-Borja M, Porter FD, Platt FM, Rolfs A. A novel, highly sensitive and specific biomarker for Niemann\u2013Pick type C1 disease. Orphanet J Rare Dis. 2015;10:78.","journal-title":"Orphanet J Rare Dis"},{"key":"2686_CR73","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cca.2016.01.003","volume":"455","author":"M Romanello","year":"2016","unstructured":"Romanello M, Zampieri S, Bortolotti N, Deroma L, Sechi A, Fiumara A, Parini R, Borroni B, Brancati F, Bruni A, Russo CV, Bordugo A, Bembi B, Dardis A. Comprehensive evaluation of Plasma 7-Ketocholesterol and cholestan-3\u03b2,5\u03b1,6\u03b2-triol in an Italian cohort of patients affected by Niemann\u2013Pick disease due to NPC1 and SMPD1 mutations. Clin Chim Acta. 2016;455:39\u201345.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"2686_CR74","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ymgme.2016.06.004","volume":"118","author":"MT Vanier","year":"2016","unstructured":"Vanier MT, Gissen P, Bauer P, Coll MJ, Burlina A, Hendriksz CJ, Latour P, Goizet C, Welford RW, Marquardt T, Kolb SA. Diagnostic tests for Niemann\u2013Pick disease type C (NP-C): a critical review. Mol Genet Metab. 2016;118(4):244\u201354.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"2686_CR75","first-page":"S62","volume":"117","author":"X Jiang","year":"2016","unstructured":"Jiang X, Sidhu R, Dietzen DJ, Yanjanin Farhat N, Porter FD, Schaffer JE, et al. Improved diagnostics for Niemann\u2013Pick disease type C based on a novel bile acid biomarker. Mol Genet Metab. 2016;117(2):S62.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"2686_CR76","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ymgme.2020.11.005","volume":"131","author":"R Sidhu","year":"2020","unstructured":"Sidhu R, Kell P, Dietzen DJ, Farhat NY, Do AND, Porter FD, Berry-Kravis E, Reunert J, Marquardt T, Giugliani R, Louren\u00e7o CM, Wang RY, Movsesyan N, Plummer E, Schaffer JE, Ory DS, Jiang X. Application of a glycinated bile acid biomarker for diagnosis and assessment of response to treatment in Niemann\u2013pick disease type C1. Mol Genet Metab. 2020;131(4):405\u201317.","journal-title":"Mol Genet Metab"},{"key":"2686_CR77","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ab.2017.02.019","volume":"525","author":"L Kuchar","year":"2017","unstructured":"Kuchar L, Sikora J, Gulinello ME, Poupetova H, Lugowska A, Malinova V, Jahnova H, Asfaw B, Ledvinova J. Quantitation of plasmatic lysosphingomyelin and lysosphingomyelin-509 for differential screening of Niemann\u2013Pick A\/B and C diseases. Anal Biochem. 2017;525:73\u20137.","journal-title":"Anal Biochem"},{"issue":"3","key":"2686_CR78","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1515\/cclm-2016-0340","volume":"55","author":"G Polo","year":"2017","unstructured":"Polo G, Burlina AP, Kolamunnage TB, Zampieri M, Dionisi-Vici C, Strisciuglio P, Zaninotto M, Plebani M, Burlina AB. Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC\u2013MS\/MS. Clin Chem Lab Med. 2017;55(3):403\u201314.","journal-title":"Clin Chem Lab Med"},{"issue":"7","key":"2686_CR79","doi-asserted-by":"publisher","first-page":"e0181700","DOI":"10.1371\/journal.pone.0181700","volume":"12","author":"M Pettazzoni","year":"2017","unstructured":"Pettazzoni M, Froissart R, Pagan C, Vanier MT, Ruet S, Latour P, Guffon N, Fouilhoux A, Germain DP, Levade T, Vianey-Saban C, Piraud M, Cheillan D. LC\u2013MS\/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: a novel tool for the screening of sphingolipidoses and Niemann\u2013Pick type C disease. PLoS ONE. 2017;12(7):e0181700.","journal-title":"PLoS ONE"},{"issue":"2","key":"2686_CR80","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ymgme.2017.12.431","volume":"123","author":"M Voorink-Moret","year":"2018","unstructured":"Voorink-Moret M, Goorden SMI, van Kuilenburg ABP, Wijburg FA, Ghauharali-van der Vlugt JMM, Beers-Stet FS, Zoetekouw A, Kulik W, Hollak CEM, Vaz FM. Rapid screening for lipid storage disorders using biochemical markers. Expert center data and review of the literature. Mol Genet Metab. 2018;123(2):76\u201384.","journal-title":"Mol Genet Metab"},{"key":"2686_CR81","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cca.2018.08.039","volume":"486","author":"F Deodato","year":"2018","unstructured":"Deodato F, Boenzi S, Taurisano R, Semeraro M, Sacchetti E, Carrozzo R, Dionisi-Vici C. The impact of biomarkers analysis in the diagnosis of Niemann\u2013Pick C disease and acid sphingomyelinase deficiency. Clin Chim Acta. 2018;486:387\u201394.","journal-title":"Clin Chim Acta"},{"issue":"12","key":"2686_CR82","doi-asserted-by":"publisher","first-page":"e114669","DOI":"10.1371\/journal.pone.0114669","volume":"9","author":"RW Welford","year":"2014","unstructured":"Welford RW, Garzotti M, Marques Louren\u00e7o C, Mengel E, Marquardt T, Reunert J, Amraoui Y, Kolb SA, Morand O, Groenen P. Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann\u2013Pick disease type C in a retrospective study. PLoS ONE. 2014;9(12):e114669.","journal-title":"PLoS ONE"},{"issue":"10","key":"2686_CR83","doi-asserted-by":"publisher","first-page":"e0140683","DOI":"10.1371\/journal.pone.0140683","volume":"10","author":"N El-Najjar","year":"2015","unstructured":"El-Najjar N, Ors\u00f3 E, Wallner S, Liebisch G, Schmitz G. Increased levels of sphingosylphosphorylcholine (SPC) in Plasma of metabolic syndrome patients. PLOS ONE. 2015;10(10):e0140683.","journal-title":"PLOS ONE"},{"key":"2686_CR84","doi-asserted-by":"publisher","first-page":"100780","DOI":"10.1016\/j.ymgmr.2021.100780","volume":"28","author":"MS Breilyn","year":"2021","unstructured":"Breilyn MS, Zhang W, Yu C, Wasserstein MP. Plasma lyso-sphingomyelin levels are positively associated with clinical severity in acid sphingomyelinase deficiency. Mol Genet Metab Rep. 2021;28:100780.","journal-title":"Mol Genet Metab Rep"},{"issue":"8","key":"2686_CR85","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/s41436-021-01156-3","volume":"23","author":"GA Diaz","year":"2021","unstructured":"Diaz GA, Jones SA, Scarpa M, Mengel KE, Giugliani R, Guffon N, Batsu I, Fraser PA, Li J, Zhang Q, Ortemann-Renon C. One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency. Genet Med. 2021;23(8):1543\u201350.","journal-title":"Genet Med"},{"issue":"7","key":"2686_CR86","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.gim.2022.03.021","volume":"24","author":"M Wasserstein","year":"2022","unstructured":"Wasserstein M, Lachmann R, Hollak C, Arash-Kaps L, Barbato A, Gallagher RC, Giugliani R, Guelbert NB, Ikezoe T, Lidove O, Mabe P, Mengel E, Scarpa M, Senates E, Tchan M, Villarrubia J, Chen Y, Furey S, Thurberg BL, Zaher A, Kumar M. A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: one-year results. Genet Med. 2022;24(7):1425\u201336.","journal-title":"Genet Med"},{"issue":"8","key":"2686_CR87","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1194\/jlr.RA119000157","volume":"60","author":"R Sidhu","year":"2019","unstructured":"Sidhu R, Mondjinou Y, Qian M, Song H, Kumar AB, Hong X, Hsu FF, Dietzen DJ, Yanjanin NM, Porter FD, Berry-Kravis E, Vite CH, Gelb MH, Schaffer JE, Ory DS, Jiang X. N-acyl-O-phosphocholineserines: structures of a novel class of lipids that are biomarkers for Niemann\u2013Pick C1 disease. J Lipid Res. 2019;60(8):1410\u201324.","journal-title":"J Lipid Res"},{"issue":"20","key":"2686_CR88","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.3390\/ijms20205018","volume":"20","author":"M Maekawa","year":"2019","unstructured":"Maekawa M, Jinnoh I, Matsumoto Y, Narita A, Mashima R, Takahashi H, Iwahori A, Saigusa D, Fujii K, Abe A, Higaki K, Yamauchi S, Ozeki Y, Shimoda K, Tomioka Y, Okuyama T, Eto Y, Ohno K, Clayton TP, Yamaguchi H, Mano N. Structural determination of lysosphingomyelin-509 and discovery of novel class lipids from patients with Niemann\u2013Pick disease type C. Int J Mol Sci. 2019;20(20):5018.","journal-title":"Int J Mol Sci."},{"issue":"4","key":"2686_CR89","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ymgme.2020.01.007","volume":"129","author":"R Sidhu","year":"2020","unstructured":"Sidhu R, Kell P, Dietzen DJ, Farhat NY, Do AND, Porter FD, Berry-Kravis E, Vite CH, Reunert J, Marquardt T, Giugliani R, Louren\u00e7o CM, Bodamer O, Wang RY, Plummer E, Schaffer JE, Ory DS, Jiang X. Application of N-palmitoyl-O-phosphocholineserine for diagnosis and assessment of response to treatment in Niemann\u2013Pick type C disease. Mol Genet Metab. 2020;129(4):292\u2013302.","journal-title":"Mol Genet Metab"},{"issue":"9","key":"2686_CR90","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1248\/bpb.b20-00400","volume":"43","author":"A Iwahori","year":"2020","unstructured":"Iwahori A, Maekawa M, Narita A, Kato A, Sato T, Ogura J, Sato Y, Kikuchi M, Noguchi A, Higaki K, Okuyama T, Takahashi T, Eto Y, Mano N. Development of a diagnostic screening strategy for Niemann\u2013Pick diseases based on simultaneous liquid chromatography-tandem mass spectrometry analyses of N-Palmitoyl-O-phosphocholine-serine and sphingosylphosphorylcholine. Biol Pharm Bull. 2020;43(9):1398\u2013406.","journal-title":"Biol Pharm Bull"},{"issue":"12","key":"2686_CR91","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1515\/cclm-2018-1301","volume":"57","author":"G Polo","year":"2019","unstructured":"Polo G, Burlina AP, Ranieri E, Colucci F, Rubert L, Pascarella A, Duro G, Tummolo A, Padoan A, Plebani M, Burlina AB. Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study. Clin Chem Lab Med. 2019;57(12):1863\u201374.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"2686_CR92","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s13023-022-02560-x","volume":"17","author":"F Kubaski","year":"2022","unstructured":"Kubaski F, Burlina A, Pereira D, Silva C, Herbst ZM, Trapp FB, et al. Quantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiency. Orphanet J Rare Dis. 2022;17(1):407.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2686_CR93","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0888-7543(91)90246-B","volume":"9","author":"L da Veiga-Pereira","year":"1991","unstructured":"da Veiga-Pereira L, Desnick RJ, Adler DA, Disteche CM, Schuchman EH. Regional assignment of the human acid sphingomyelinase gene (SMPD1) by PCR analysis of somatic cell hybrids and in situ hybridization to 11p15.1\u2013p15.4. Genomics. 1991;9(2):229\u201334.","journal-title":"Genomics"},{"issue":"9","key":"2686_CR94","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/j.1460-2075.1989.tb08382.x","volume":"8","author":"LE Quintern","year":"1989","unstructured":"Quintern LE, Schuchman EH, Levran O, Suchi M, Ferlinz K, Reinke H, Sandhoff K, Desnick RJ. Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts. EMBO J. 1989;8(9):2469\u201373.","journal-title":"EMBO J"},{"issue":"13","key":"2686_CR95","doi-asserted-by":"publisher","first-page":"8531","DOI":"10.1016\/S0021-9258(18)93007-3","volume":"266","author":"EH Schuchman","year":"1991","unstructured":"Schuchman EH, Suchi M, Takahashi T, Sandhoff K, Desnick RJ. Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs. J Biol Chem. 1991;266(13):8531\u20139.","journal-title":"J Biol Chem."},{"issue":"1","key":"2686_CR96","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s004390100505","volume":"109","author":"JT den Dunnen","year":"2001","unstructured":"den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Genet. 2001;109(1):121\u20134.","journal-title":"Hum Genet"},{"issue":"4","key":"2686_CR97","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jmoldx.2020.01.010","volume":"22","author":"A Zanetti","year":"2020","unstructured":"Zanetti A, D\u2019Avanzo F, Bertoldi L, Zampieri G, Feltrin E, De Pascale F, Rampazzo A, Forzan M, Valle G, Tomanin R. Setup and validation of a targeted next-generation sequencing approach for the diagnosis of lysosomal storage disorders. J Mol Diagn. 2020;22(4):488\u2013502.","journal-title":"J Mol Diagn"},{"issue":"18","key":"2686_CR98","doi-asserted-by":"publisher","first-page":"10064","DOI":"10.3390\/ijms221810064","volume":"22","author":"V La Cognata","year":"2021","unstructured":"La Cognata V, Guarnaccia M, Morello G, Ruggieri M, Polizzi A, Cavallaro S. Design and validation of a custom NGS panel targeting a set of lysosomal storage diseases candidate for NBS applications. Int J Mol Sci. 2021;22(18):10064.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2686_CR99","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med."},{"issue":"10","key":"2686_CR100","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1002\/ajmg.a.37817","volume":"170","author":"P Ranganath","year":"2016","unstructured":"Ranganath P, Matta D, Bhavani GS, Wangnekar S, Jain JM, Verma IC, Kabra M, Puri RD, Danda S, Gupta N, Girisha KM, Sankar VH, Patil SJ, Ramadevi AR, Bhat M, Gowrishankar K, Mandal K, Aggarwal S, Tamhankar PM, Tilak P, Phadke SR, Dalal A. Spectrum of SMPD1 mutations in Asian-Indian patients with acid sphingomyelinase (ASM)-deficient Niemann\u2013Pick disease. Am J Med Genet A. 2016;170(10):2719\u201330.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"2686_CR101","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/humu.9258","volume":"24","author":"V Ricci","year":"2004","unstructured":"Ricci V, Stroppiano M, Corsolini F, Di Rocco M, Parenti G, Regis S, Grossi S, Biancheri R, Mazzotti R, Filocamo M. Screening of 25 Italian patients with Niemann\u2013Pick a reveals fourteen new mutations, one common and thirteen private, in SMPD1. Hum Mutat. 2004;24(1):105.","journal-title":"Hum Mutat"},{"issue":"2","key":"2686_CR102","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/humu.9263","volume":"24","author":"MG Pittis","year":"2004","unstructured":"Pittis MG, Ricci V, Guerci VI, Mar\u00e7ais C, Ciana G, Dardis A, Gerin F, Stroppiano M, Vanier MT, Filocamo M, Bembi B. Acid sphingomyelinase: identification of nine novel mutations among Italian Niemann Pick type B patients and characterization of in vivo functional in-frame start codon. Hum Mutat. 2004;24(2):186\u20137.","journal-title":"Hum Mutat"},{"issue":"7","key":"2686_CR103","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/humu.21018","volume":"30","author":"L Rodr\u00edguez-Pascau","year":"2009","unstructured":"Rodr\u00edguez-Pascau L, Gort L, Schuchman EH, Vilageliu L, Grinberg D, Chab\u00e1s A. Identification and characterization of SMPD1 mutations causing Niemann\u2013Pick types A and B in Spanish patients. Hum Mutat. 2009;30(7):1117\u201322.","journal-title":"Hum Mutat"},{"issue":"6","key":"2686_CR104","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1086\/345074","volume":"71","author":"CM Simonaro","year":"2002","unstructured":"Simonaro CM, Desnick RJ, McGovern MM, Wasserstein MP, Schuchman EH. The demographics and distribution of type B Niemann\u2013Pick disease: novel mutations lead to new genotype\/phenotype correlations. Am J Hum Genet. 2002;71(6):1413\u20139.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2686_CR105","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.gene.2013.03.116","volume":"526","author":"A Aykut","year":"2013","unstructured":"Aykut A, Karaca E, Onay H, Ucar SK, Coker M, Cogulu O, Ozkinay F. Analysis of the sphingomyelin phosphodiesterase 1 gene (SMPD1) in Turkish Niemann\u2013Pick disease patients: mutation profile and description of a novel mutation. Gene. 2013;526(2):484\u20136.","journal-title":"Gene"},{"key":"2686_CR106","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1750-1172-8-15","volume":"8","author":"H Zhang","year":"2013","unstructured":"Zhang H, Wang Y, Gong Z, Li X, Qiu W, Han L, Ye J, Gu X. Identification of a distinct mutation spectrum in the SMPD1 gene of Chinese patients with acid sphingomyelinase-deficient Niemann\u2013Pick disease. Orphanet J Rare Dis. 2013;8:15.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"2686_CR107","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/humu.24192","volume":"42","author":"J Hu","year":"2021","unstructured":"Hu J, Maegawa GHB, Zhan X, Gao X, Wang Y, Xu F, Qiu W, Han L, Gu X, Zhang H. Clinical, biochemical, and genotype-phenotype correlations of 118 patients with Niemann\u2013Pick disease types A\/B. Hum Mutat. 2021;42(5):614\u201325.","journal-title":"Hum Mutat"},{"issue":"4","key":"2686_CR108","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/BF01247328","volume":"92","author":"MT Vanier","year":"1993","unstructured":"Vanier MT, Ferlinz K, Rousson R, Duthel S, Louisot P, Sandhoff K, Suzuki K. Deletion of arginine (608) in acid sphingomyelinase is the prevalent mutation among Niemann\u2013Pick disease type B patients from northern Africa. Hum Genet. 1993;92(4):325\u201330.","journal-title":"Hum Genet"},{"issue":"2","key":"2686_CR109","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/humu.22923","volume":"37","author":"S Zampieri","year":"2016","unstructured":"Zampieri S, Filocamo M, Pianta A, Lualdi S, Gort L, Coll MJ, Sinnott R, Geberhiwot T, Bembi B, Dardis A. SMPD1 Mutation update: database and comprehensive analysis of published and novel variants. Hum Mutat. 2016;37(2):139\u201347.","journal-title":"Hum Mutat"},{"issue":"2","key":"2686_CR110","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/humu.9353","volume":"26","author":"A Dardis","year":"2005","unstructured":"Dardis A, Zampieri S, Filocamo M, Burlina A, Bembi B, Pittis MG. Functional in vitro characterization of 14 SMPD1 mutations identified in Italian patients affected by Niemann Pick type B disease. Hum Mutat. 2005;26(2):164.","journal-title":"Hum Mutat"},{"issue":"3","key":"2686_CR111","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1034\/j.1399-0004.2003.00025.x","volume":"63","author":"M Fern\u00e1ndez-Burriel","year":"2003","unstructured":"Fern\u00e1ndez-Burriel M, Pe\u00f1a L, Ramos JC, Cabrera JC, Marti M, Rodr\u00edguez-Qui\u00f1ones F, Chab\u00e1s A. The R608del mutation in the acid sphingomyelinase gene (SMPD1) is the most prevalent among patients from Gran Canaria Island with Niemann\u2013Pick disease type B. Clin Genet. 2003;63(3):235\u20136.","journal-title":"Clin Genet"},{"issue":"5","key":"2686_CR112","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.revmed.2016.10.387","volume":"38","author":"O Lidove","year":"2017","unstructured":"Lidove O, Belmatoug N, Froissart R, Lavigne C, Durieu I, Mazodier K, Serratrice C, Douillard C, Goizet C, Cathebras P, Besson G, Amoura Z, Tazi A, Gatfoss\u00e9 M, Rivi\u00e8re S, Sen\u00e9 T, Vanier MT, Ziza JM. D\u00e9ficit en sphingomy\u00e9linase acide (maladie de Niemann\u2013Pick B): une \u00e9tude r\u00e9trospective multicentrique de 28 patients adultes [Acid sphingomyelinase deficiency (Niemann\u2013Pick disease type B) in adulthood: a retrospective multicentric study of 28 adult cases]. Rev Med Interne. 2017;38(5):291\u20139.","journal-title":"Rev Med Interne"},{"issue":"3","key":"2686_CR113","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1172\/JCI115380","volume":"88","author":"O Levran","year":"1991","unstructured":"Levran O, Desnick RJ, Schuchman EH. Niemann\u2013Pick type B disease. Identification of a single codon deletion in the acid sphingomyelinase gene and genotype\/phenotype correlations in type A and B patients. J Clin Invest. 1991;88(3):806\u201310.","journal-title":"J Clin Invest"},{"issue":"8","key":"2686_CR114","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1182\/blood.V80.8.2081.2081","volume":"80","author":"O Levran","year":"1992","unstructured":"Levran O, Desnick RJ, Schuchman EH. Identification and expression of a common missense mutation (L302P) in the acid sphingomyelinase gene of Ashkenazi Jewish type A Niemann\u2013Pick disease patients. Blood. 1992;80(8):2081\u20137.","journal-title":"Blood"},{"issue":"9","key":"2686_CR115","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.1073\/pnas.88.9.3748","volume":"88","author":"O Levran","year":"1991","unstructured":"Levran O, Desnick RJ, Schuchman EH. Niemann\u2013Pick disease: a frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients. Proc Natl Acad Sci USA. 1991;88(9):3748\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2686_CR116","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/humu.1380020414","volume":"2","author":"O Levran","year":"1993","unstructured":"Levran O, Desnick RJ, Schuchman EH. Type A Niemann\u2013Pick disease: a frameshift mutation in the acid sphingomyelinase gene (fsP330) occurs in Ashkenazi Jewish patients. Hum Mutat. 1993;2(4):317\u20139.","journal-title":"Hum Mutat"},{"issue":"160","key":"2686_CR117","doi-asserted-by":"publisher","first-page":"200363","DOI":"10.1183\/16000617.0363-2020","volume":"30","author":"R Borie","year":"2021","unstructured":"Borie R, Crestani B, Guyard A, Lidove O. Interstitial lung disease in lysosomal storage disorders. Eur Respir Rev. 2021;30(160):200363.","journal-title":"Eur Respir Rev"},{"issue":"23","key":"2686_CR118","doi-asserted-by":"publisher","first-page":"12870","DOI":"10.3390\/ijms222312870","volume":"22","author":"C Pinto","year":"2021","unstructured":"Pinto C, Sousa D, Ghilas V, Dardis A, Scarpa M, Macedo MF. Acid sphingomyelinase deficiency: a clinical and immunological perspective. Int J Mol Sci. 2021;22(23):12870.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2686_CR119","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ymgme.2018.11.014","volume":"126","author":"M Wasserstein","year":"2019","unstructured":"Wasserstein M, Dionisi-Vici C, Giugliani R, Hwu WL, Lidove O, Lukacs Z, Mengel E, Mistry PK, Schuchman EH, McGovern M. Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD). Mol Genet Metab. 2019;126(2):98\u2013105.","journal-title":"Mol Genet Metab"},{"key":"2686_CR120","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13023-015-0366-y","volume":"10","author":"S Van Groenendael","year":"2015","unstructured":"Van Groenendael S, Giacovazzi L, Davison F, Holtkemper O, Huang Z, Wang Q, Parkinson K, Barrett T, Geberhiwot T. High quality, patient centred and coordinated care for Alstrom syndrome: a model of care for an ultra-rare disease. Orphanet J Rare Dis. 2015;10:149.","journal-title":"Orphanet J Rare Dis"},{"issue":"1\u20132","key":"2686_CR121","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ymgme.2020.06.008","volume":"131","author":"SA Jones","year":"2020","unstructured":"Jones SA, McGovern M, Lidove O, Giugliani R, Mistry PK, Dionisi-Vici C, Munoz-Rojas MV, Nalysnyk L, Schecter AD, Wasserstein M. Clinical relevance of endpoints in clinical trials for acid sphingomyelinase deficiency enzyme replacement therapy. Mol Genet Metab. 2020;131(1\u20132):116\u201323.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"2686_CR122","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/ijms20020327","volume":"20","author":"P Faverio","year":"2019","unstructured":"Faverio P, Stainer A, De Giacomi F, Gasperini S, Motta S, Canonico F, Pieruzzi F, Monzani A, Pesci A, Biondi A. Molecular pathways and respiratory involvement in lysosomal storage diseases. Int J Mol Sci. 2019;20(2):327.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2686_CR123","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ajmg.10278","volume":"109","author":"P Volders","year":"2002","unstructured":"Volders P, Van Hove J, Lories RJ, Vandekerckhove P, Matthijs G, De Vos R, Vanier MT, Vincent MF, Westhovens R, Luyten FP. Niemann\u2013Pick disease type B: an unusual clinical presentation with multiple vertebral fractures. Am J Med Genet. 2002;109(1):42\u201351.","journal-title":"Am J Med Genet"},{"issue":"1","key":"2686_CR124","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/gim.2015.24","volume":"18","author":"MM McGovern","year":"2016","unstructured":"McGovern MM, Wasserstein MP, Kirmse B, Duvall WL, Schiano T, Thurberg BL, Richards S, Cox GF. Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann\u2013Pick disease type B (acid sphingomyelinase deficiency). Genet Med. 2016;18(1):34\u201340.","journal-title":"Genet Med"},{"issue":"1\u20132","key":"2686_CR125","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ymgme.2015.05.013","volume":"116","author":"MP Wasserstein","year":"2015","unstructured":"Wasserstein MP, Jones SA, Soran H, Diaz GA, Lippa N, Thurberg BL, Culm-Merdek K, Shamiyeh E, Inguilizian H, Cox GF, Puga AC. Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency. Mol Genet Metab. 2015;116(1\u20132):88\u201397.","journal-title":"Mol Genet Metab"},{"issue":"9","key":"2686_CR126","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1097\/PAS.0000000000000659","volume":"40","author":"BL Thurberg","year":"2016","unstructured":"Thurberg BL, Wasserstein MP, Jones SA, Schiano TD, Cox GF, Puga AC. Clearance of hepatic sphingomyelin by Olipudase alfa is associated with improvement in lipid profiles in acid sphingomyelinase deficiency. Am J Surg Pathol. 2016;40(9):1232\u201342.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2686_CR127","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s10545-017-0123-6","volume":"41","author":"MP Wasserstein","year":"2018","unstructured":"Wasserstein MP, Diaz GA, Lachmann RH, Jouvin MH, Nandy I, Ji AJ, Puga AC. Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months. J Inherit Metab Dis. 2018;41(5):829\u201338.","journal-title":"J Inherit Metab Dis"},{"issue":"1\u20132","key":"2686_CR128","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ymgme.2020.06.010","volume":"131","author":"BL Thurberg","year":"2020","unstructured":"Thurberg BL, Diaz GA, Lachmann RH, Schiano T, Wasserstein MP, Ji AJ, Zaher A, Peterschmitt MJ. Long-term efficacy of olipudase alfa in adults with acid sphingomyelinase deficiency (ASMD): further clearance of hepatic sphingomyelin is associated with additional improvements in pro- and anti-atherogenic lipid profiles after 42 months of treatment. Mol Genet Metab. 2020;131(1\u20132):245\u201352.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"2686_CR129","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s13023-022-02587-0","volume":"17","author":"GA Diaz","year":"2022","unstructured":"Diaz GA, Giugliani R, Guffon N, Jones SA, Mengel E, Scarpa M, Witters P, Yarramaneni A, Li J, Armstrong NM, Kim Y, Ortemann-Renon C, Kumar M. Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results. Orphanet J Rare Dis. 2022;17(1):437.","journal-title":"Orphanet J Rare Dis"},{"key":"2686_CR130","doi-asserted-by":"publisher","first-page":"100957","DOI":"10.1016\/j.ymgmr.2023.100957","volume":"34","author":"YW Pan","year":"2023","unstructured":"Pan YW, Tsai MC, Yang CY, Yu WH, Wang B, Yang YJ, Chou YY. Enzyme replacement therapy for children with acid sphingomyelinase deficiency in the real world: a single center experience in Taiwan. Mol Genet Metab Rep. 2023;34:100957.","journal-title":"Mol Genet Metab Rep"},{"issue":"4","key":"2686_CR131","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3390\/jcm11040920","volume":"11","author":"W Mauhin","year":"2022","unstructured":"Mauhin W, Borie R, Dalbies F, Douillard C, Guffon N, Lavigne C, Lidove O, Brassier A. Acid sphingomyelinase deficiency: sharing experience of disease monitoring and severity in France. J Clin Med. 2022;11(4):920.","journal-title":"J Clin Med"},{"issue":"10","key":"2686_CR132","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1016\/j.transproceed.2015.10.051","volume":"47","author":"GR Coelho","year":"2015","unstructured":"Coelho GR, Praciano AM, Rodrigues JP, Viana CF, Brand\u00e3o KP, Valenca JT Jr, Garcia JH. Liver transplantation in patients with Niemann\u2013Pick disease-single-center experience. Transpl Proc. 2015;47(10):2929\u201331.","journal-title":"Transpl Proc"},{"issue":"8","key":"2686_CR133","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/lt.25457","volume":"25","author":"Y Liu","year":"2019","unstructured":"Liu Y, Luo Y, Xia L, Qiu B, Zhou T, Feng M, Xue F, Chen X, Han L, Zhang J, Xia Q. The effects of liver transplantation in children with Niemann\u2013Pick disease type B. Liver Transpl. 2019;25(8):1233\u201340.","journal-title":"Liver Transpl"},{"issue":"1","key":"2686_CR134","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1164\/ajrccm.165.1.2103113","volume":"165","author":"AG Nicholson","year":"2002","unstructured":"Nicholson AG, Wells AU, Hooper J, Hansell DM, Kelleher A, Morgan C. Successful treatment of endogenous lipoid pneumonia due to Niemann\u2013Pick type B disease with whole-lung lavage. Am J Respir Crit Care Med. 2002;165(1):128\u201331.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2686_CR135","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/ppul.20248","volume":"40","author":"ZS Uyan","year":"2005","unstructured":"Uyan ZS, Karada\u011f B, Ersu R, Kiyan G, Kotilo\u011flu E, Sirvanci S, Ercan F, Da\u011fli T, Karako\u00e7 F, Da\u011fli E. Early pulmonary involvement in Niemann\u2013Pick type B disease: lung lavage is not useful. Pediatr Pulmonol. 2005;40(2):169\u201372.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"2686_CR136","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.healun.2018.10.002","volume":"38","author":"H Mannem","year":"2019","unstructured":"Mannem H, Kilbourne S, Weder M. Lung transplantation in a patient with Niemann\u2013Pick disease. J Heart Lung Transpl. 2019;38(1):100\u20131.","journal-title":"J Heart Lung Transpl"},{"key":"2686_CR137","first-page":"9431751","volume":"2019","author":"RS O'Neill","year":"2019","unstructured":"O\u2019Neill RS, Belousova N, Malouf MA. Pulmonary type B Niemann\u2013Pick disease successfully treated with lung transplantation. Case Rep Transpl. 2019;2019:9431751.","journal-title":"Case Rep Transpl"},{"issue":"5","key":"2686_CR138","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.healun.2019.01.002","volume":"38","author":"F Ding","year":"2019","unstructured":"Ding F, Mehta AC, Arrossi AV. Successful lung transplantation in a patient with Niemann\u2013Pick disease. J Heart Lung Transpl. 2019;38(5):582\u20133.","journal-title":"J Heart Lung Transpl"},{"key":"2686_CR139","first-page":"5428381","volume":"2022","author":"VMC Mora","year":"2022","unstructured":"Mora VMC, Osorio JSC, Iturbe DF, Tello SM, Guzm\u00e1n YG, S\u00e1nchez LM, G\u00f3mez JJR, Cifri\u00e1n JMM. Double-lung transplantation in a patient with pulmonary type B Niemann\u2013Pick disease: a valid treatment option. Case Rep Transpl. 2022;2022:5428381.","journal-title":"Case Rep Transpl"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02686-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02686-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02686-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T11:08:44Z","timestamp":1681729724000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02686-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":139,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2686"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02686-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2206440\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"31 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Sanofi has provided financial support to AD, AL, ES, OL, RG, SCB and TH, research grant to ES and TH, and honorarium to AD, ES, OL, MTV and RG. Honorarium has been provided by Orphazyme to AD and MTV.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}